Skip to main content

The presence of antibrain antibodies in the CSF of some Alzheimer disease patients: correlation with CSF parameters

  • Chapter
Early Markers in Parkinson’s and Alzheimer’s Diseases

Part of the book series: New Vistas in Drug Research ((DRUG RESEARCH,volume 1))

  • 76 Accesses

Summary

Our recent investigations demonstrated that antibodies in the cerebrospinal fluid (CSF) of some AD patients recognize cholinergic neuronal populations in the rat central nervous system (CNS). The present study correlated immunocytochemical markings produced by AD and control CSF samples in a cholinergic brain region with clinical and CSF protein parameters. There was a higher incidence of positive markings produced by AD CSF compared to control CSF. No correlation was noted with basic clinical data. However, the blood-brain barrier function was significantly correlated with immunocytochemical markings produced by AD CSF.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Psychiatry Association Task Force on Nomenclature and Statistics (1980) Diagnostic and Statistical Manual of Mental Disorders (DSM-III), 3rd edn. American Psychiatry Association, Washington DC

    Google Scholar 

  • Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L Blood-brain barrier disturbances in Alzheimer’s disease patients are related to vascular factors. (Submitted)

    Google Scholar 

  • Chapman J, Korczyn AD, Hareuveni M, Michaelson DM (1986) Antibodies to cholinergic cell bodies in Alzheimer’s disease. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer’s and Parkinson’s diseases: strategies for research and development. Plenum Press, New York, pp 329–336

    Google Scholar 

  • Dahlstrom A, Wigander A, Lundmark K, Gottfries CG, McRae A (1990) Investigations on autoantibodies in Alzheimer’s and Parkinson’s diseases, using defined neuronal cultures. J Neural Transm [Suppl] 29: 195–206

    CAS  Google Scholar 

  • Fillit HM, Luine VN, Reisberg B, Amador R, McEwen B, Zabriskie JB (1985) Studies of the specificity of antibrain antibodies in Alzheimer’s disease. In: Hutton JT, Kenny AD (eds) Senile dementia. Alan R Liss, New York, pp 307–318

    Google Scholar 

  • Filit HM, Kemeny E, Luine V, Weksler ME, Zabriskie JB (1987) Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer’s type. J Gerontol 42: 180–184

    Google Scholar 

  • Folstein M, Folstein S, McHugh P (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198

    Google Scholar 

  • Ishii T, Haga S (1976) Immunoelectron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques. Acta Neuropathol 36: 243–249

    Article  PubMed  CAS  Google Scholar 

  • Laurell CB (1972) Electroimmunoassay. Scand J Clin Lab Invest 29: 21–37

    Article  CAS  Google Scholar 

  • Lehman EL (1975) Nonparametrics. Holden Day, San Francisco

    Google Scholar 

  • Link H, Tibbling G (1977) Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest 37: 391–396

    Article  PubMed  CAS  Google Scholar 

  • McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944

    Google Scholar 

  • McRae-Degueurce A, Bööj S, Haglid K, Rosengren L, Karlsson JE, Karlsson I, Wallin A, Svennerholm L, Gottfries CG, Dahlström A (1987) Antibodies in the cerebrospinal fluid of some Alzheimer patients recognize cholinergic neurons in the rat central nervous system. PNAS 84: 9214–9218

    Article  PubMed  CAS  Google Scholar 

  • Wisniewski HM, Kozlowski PB (1982) Evidence for blood-brain barrier changes in senile dementia of the Alzheimer’s type. Ann NY Acad Sci 396: 119–127

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag/Wien

About this chapter

Cite this chapter

McRae, A., Blennow, K., Wallin, A., Fredman, P., Gottfries, C.G., Dahlström, A. (1990). The presence of antibrain antibodies in the CSF of some Alzheimer disease patients: correlation with CSF parameters. In: Dostert, P., Riederer, P., Strolin Benedetti, M., Roncucci, R. (eds) Early Markers in Parkinson’s and Alzheimer’s Diseases. New Vistas in Drug Research, vol 1. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9098-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9098-2_24

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-9100-2

  • Online ISBN: 978-3-7091-9098-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics